A Worcester State University-hosted vaccine clinic run by Saint Vincent Hospital is closing June 10, after administering over 83,000 coronavirus vaccines, Saint Vincent announced on Thursday.
E-Mail
LOWELL, Mass. - Biotech and medical-device entrepreneurs preparing to test their innovations in clinical trials will gain insights into that process during free programs presented by the Massachusetts Medical Device Development Center (M2D2).
The Clinical Trial Program Series, which begins next month via Zoom, will unite entrepreneurs with industry and government leaders to share best practices, challenges, funding issues and a road map for successful clinical trials. M2D2 is a joint venture of UMass Lowell and UMass Medical School in Worcester. The center assists entrepreneurs with all aspects of moving new products and technologies from the drawing board to the marketplace.
By Devan Greevy
Early data in a trial, run in part at UMass Medical School in Worcester, for adolescents indicates the Moderna COVID-19 vaccine has a 95% efficacy with no serious safety concerns to date for individuals aged 12 to 17, as the pharmaceutical company works to receive approval for the vaccine’s widespread use in children.
UMass Medical School participated in the TeenCove trial, which began in early February and is continuing to collect data using more than 3,000 adolescent participants nationwide. The research center made an effort to include participants of underserved racial and ethnic identities, who are disproportionately likely to be affected by COVID-19.
Free Events Explore the Clinical Trials Process uml.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uml.edu Daily Mail and Mail on Sunday newspapers.